Announcement Regarding the Proposed Winning of Bids in the National Organized Centralized Drug Procurement

Hunan Jiudian Pharmaceutical Co., Ltd.·August 3, 2026·2 pages

✨ AI Summary

Jiudian Pharmaceutical participated in the 12th batch of national centralized drug procurement on July 31, 2026. The company's products, Ferrous Succinate Tablets and Indobufen Tablets, were selected as proposed winners. This development is expected to expand the company's market coverage in anemia and cardiovascular treatment, though it may exert short-term pressure on profit margins due to the current pricing mechanism.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 300705 Stock Abbreviation: Jiudian Pharmaceutical

Announcement No.: 2026-039

Bond Code: 123223 Bond Abbreviation: Jiudian Convertible Bond 02

Hunan Jiudian Pharmaceutical Co., Ltd.

Announcement Regarding the Proposed Winning of Bids in the National Organized Centralized Drug Procurement

Hunan Jiudian Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") participated in the bidding for the 12th batch of national organized centralized drug procurement organized by the Joint Procurement Office on July 31, 2026. The Company's products, Ferrous Succinate Tablets and Indobufen Tablets, are proposed to be selected for this centralized procurement. The relevant details are announced as follows:

I. Basic Information of Proposed Winning Products

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.